EMG
PLX icon

ETF Managers Group’s Protalix BioTherapeutics PLX Stock Holding History

ETF Managers Group’s Portfolio PLX Stock Details PLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-101,768
Closed -$397K – 642
2020
Q3 		$397K Buy
101,768
+7,915
+8% +$28.6K 0.01% 358
2020
Q2 		$367K Buy
+93,853
New +$321K 0.01% 320
2018
Q4 		– Sell
-33,152
Closed -$221K – 590
2018
Q3 		$221K Buy
+33,152
New +$166K 0.01% 242
2017
Q3 		– Sell
-8,981
Closed -$73K – 490
2017
Q2 		$73K Buy
+8,981
New +$84.3K 0.01% 210

Other funds holding PLX

BCM
Burrage Capital Management Boston, Massachusetts $99.7M AUM 66.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.37B AUM 63.08% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return